Evidence map›Paper›PMID 25042981›Full record

ArticleThe Journal of allergy and clinical immunology2014

Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.

Oliver T Burton, Stephanie L Logsdon, Joseph S Zhou, Jaciel Medina-Tamayo, Azza Abdel-Gadir, Magali Noval Rivas, Kyle J Koleoglou, Talal A Chatila, Lynda C Schneider, Rima Rachid and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 178 citations in OpenAlex.

  1. Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral Immunotherapy.The journal of allergy and clinical immunology. In practice · 2022
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Immunoglobulin E blockade during food allergen ingestion enhances the induction of inhibitory immunoglobulin G antibodies.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2019
    Trial
  7. Omalizumab facilitates rapid oral desensitization for peanut allergy.The Journal of allergy and clinical immunology · 2017
    Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Emerging Therapies for Anaphylaxis.Immunology and allergy clinics of North America · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. IgG:FcγRIIb Signaling on Mast Cells Blocks Allergic Airway Inflammation.International journal of molecular sciences · 2025
    Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Oliver T BurtonDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Stephanie L LogsdonDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Joseph S ZhouDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Jaciel Medina-TamayoDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Azza Abdel-GadirDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Magali Noval RivasDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Kyle J KoleoglouDivision of Immunology, Boston Children's Hospital, Boston, Mass.
Talal A ChatilaDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Lynda C SchneiderDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Rima RachidDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Dale T UmetsuDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Hans C OettgenDivision of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: hans.oettgen@childrens.harvard.edu.
Boston Children's Hospital · USHarvard University · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
MOLECULAR BASIS OF ALLERGIC AND IMMUNOLOGIC DISEASET32AI007512 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI Janet Chou, Peter A Nigrovic · 1996 to 2026
$13.1M
Role of IL-4R-alpha signaling in food allergen sensitization and anaphylaxisR56AI100889 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OETTGEN, HANS C · 2012 to 2012
$290k
NCRR NIH HHS UL1 RR 025758NCRR NIH HHS UL1 RR025758NIAID NIH HHS 5T32AI007512-24NIAID NIH HHS R56 AI100889NIAID NIH HHS R56AI100889NIAID NIH HHS T32 AI007512
6 · The paper itself

Abstract

backgroundFood-induced anaphylaxis is triggered by specific IgE antibodies. Paradoxically, some subjects with significant IgE levels can ingest allergenic foods without incident. Similarly, subjects completing oral immunotherapy (OIT) tolerate food challenges despite persistent high-titer food-specific IgE.

objectiveWe sought to test whether IgG antibodies induced by food immunotherapy prevent food-induced anaphylaxis and whether this occurs through the inhibitory receptor FcγRIIb.

methodsFood allergy-susceptible Il4raF709 mice were enterally sensitized to ovalbumin (OVA). Similarly sensitized IgE-deficient (IgE(-/-)) Il4raF709 mice, which can ingest OVA without anaphylaxis, were subjected to a high-dose enteral OVA desensitization protocol (OIT). Sera from both groups were tested for the ability to activate or inhibit bone marrow mast cells (BMMCs) exposed to allergen or to passively transfer allergy to naive hosts. In parallel experiments sera obtained from patients with peanut allergy before and after undergoing OIT were interrogated for their ability to enhance or suppress peanut-induced activation in an indirect assay by using basophils from nonallergic donors.

resultsIl4raF709 mice exhibited strong OVA-specific IgE responses. Their sera efficiently sensitized BMMCs for activation by antigen challenge. Sera from Il4raF709/IgE(-/-) mice subjected to OVA OIT suppressed BMMC responses. This inhibition was IgG mediated and FcγRIIb dependent. Similarly, pre-OIT but not post-OIT sera from patients efficiently sensitized basophils for peanut-induced activation. IgG antibodies in post-OIT sera suppressed basophil activation by pre-OIT sera. This inhibition was blocked by antibodies against FcγRII.

conclusionFood-specific IgG antibodies, such as those induced during OIT, inhibit IgE-mediated reactions. Strategies that favor IgG responses might prove useful in the management of food allergy.

Indexed as

Desensitization, ImmunologicAdministration, OralAdolescentAllergensAnimalsBasophilsChildFemaleFoodHumansHypersensitivity, ImmediateImmunoglobulin GMaleMast CellsMice, TransgenicOvalbuminAllergensFcgr2b protein, mouseImmunoglobulin GOvalbuminReceptors, IgGanaphylaxisdesensitizationFood allergyIgEoral immunotherapytolerance

Identifiers

PMID25042981
PMCPMC4261076
OpenAlexW2046984705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.